Get the Stockscreener App
59.27
0.90%
0.53
After Hours:
59.25
-0.02
-0.03%
Overview
News
Price History
Option Chain
Financials
Why BMY Down?
Discussions
Forecast
Stock Split
Dividend History
Bristol Myers Squibb Co Stock (BMY) Forecast
The Bristol Myers Squibb Co (BMY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $55.28, representing a -6.73% decrease from the current price of $59.27. The highest analyst price target is $58.06, and the lowest is $52.50.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BMY Price Target
Average 54.26
(-8.46% Downside)
Is Bristol Myers Squibb Co (BMY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.74 | Neutral |
| STOCH(9,6) | 59.39 | Neutral |
| STOCHRSI(14) | 53.38 | Neutral |
| MACD(12,26) | 1.4624 | Buy |
| ADX(14) | 32.90 | Buy |
| William %R | -25.46 | Neutral |
| CCI(14) | 64.58 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
58.15
Buy
|
58.24
Buy
|
| MA20 |
57.22
Buy
|
57.15
Buy
|
| MA50 |
54.21
Buy
|
54.56
Buy
|
| MA100 |
50.68
Buy
|
52.01
Buy
|
| MA200 |
48.68
Buy
|
51.01
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, BMY could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on BMY, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.74 indicates that BMY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.39 indicates that BMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 53.38 indicates that BMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.9 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 64.58 indicates that BMY is still overbought but not to an extreme extent.
Long-term BMY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bristol Myers Squibb Co financial reports and earnings history, Bristol Myers Squibb Co (BMY) stock could reach $42.39 by 2030, $63.00 by 2040 and $57.40 by 2050. See the projected annual prices until 2050 of the Bristol Myers Squibb Co stock below:
- Bristol Myers Squibb Co (BMY) is expected to reach an average price of $44.43 in 2035, with a high prediction of $48.21 and a low estimate of $43.09. This indicates an $-25.04% rise from the last recorded price of $59.27.
- Bristol Myers Squibb Co (BMY) stock is projected to chart a bullish course in 2040, with an average price target of $58.71, representing an $-0.94% surge from its current level. The forecast ranges from a conservative $57.96 to a sky-high $63.00.
- Our analysts predict Bristol Myers Squibb Co (BMY) to jump -0.66% by 2045, soaring from $58.37 to an average price of $58.88, potentially reaching $65.16. While $58.37 is the low estimate, the potential upside is significant.
- Bristol Myers Squibb Co (BMY) stock is expected to climb by 2050, reaching an average of $57.40, a $-3.16% jump from its current level. However, a wide range of estimates exists, with high and low targets of $57.40 and $53.66, respectively, highlighting the market's uncertainty.
Bristol Myers Squibb Co Stock (BMY) Year by Year Forecast
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2024
Our forecast for BMY stock price in 2024 now indicates an average price target of $48.86 with a high forecast of $58.06 and a low forecast of $39.67. The average prediction reflects an decrease of -17.56% from the last recorded price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $57.34 | $52.50 | $58.06 | -3.25% |
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2025
Bristol Myers Squibb Co Stock (BMY) is expected to reach an average price of $54.26 in 2025, with a high prediction of $65.54 and a low estimate of $42.97. This indicates an -8.46% fall from the last recorded price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $60.09 | $57.60 | $61.95 | +1.39% |
| February, 2025 | $59.97 | $59.71 | $65.54 | +1.19% |
| March, 2025 | $54.59 | $53.59 | $65.00 | -7.90% |
| April, 2025 | $52.82 | $42.97 | $59.06 | -10.88% |
| May, 2025 | $59.01 | $50.73 | $60.05 | -0.44% |
| June, 2025 | $61.40 | $56.89 | $62.55 | +3.60% |
| July, 2025 | $53.57 | $51.29 | $62.42 | -9.62% |
| August, 2025 | $54.65 | $53.14 | $57.90 | -7.80% |
| September, 2025 | $58.24 | $54.50 | $60.19 | -1.74% |
| October, 2025 | $57.17 | $56.47 | $61.49 | -3.54% |
| November, 2025 | $57.52 | $54.13 | $58.17 | -2.96% |
| December, 2025 | $55.68 | $53.98 | $59.65 | -6.06% |
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2026
The predicted value for Bristol Myers Squibb Co (BMY) in 2026 is set at an average of $61.44. Estimates vary from a peak of $67.01 to a trough of $55.87, indicating an +3.65% surge from the present price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $60.28 | $56.07 | $63.46 | +1.71% |
| February, 2026 | $60.37 | $57.15 | $60.97 | +1.86% |
| March, 2026 | $63.78 | $57.70 | $64.10 | +7.60% |
| April, 2026 | $57.84 | $56.61 | $64.40 | -2.41% |
| May, 2026 | $59.94 | $55.87 | $60.48 | +1.13% |
| June, 2026 | $59.85 | $58.92 | $61.66 | +0.99% |
| July, 2026 | $62.13 | $58.76 | $64.17 | +4.82% |
| August, 2026 | $64.59 | $60.47 | $65.21 | +8.97% |
| September, 2026 | $64.41 | $62.49 | $65.11 | +8.68% |
| October, 2026 | $65.35 | $63.03 | $66.59 | +10.27% |
| November, 2026 | $64.12 | $63.77 | $67.01 | +8.18% |
| December, 2026 | $56.42 | $56.41 | $64.55 | -4.81% |
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bristol Myers Squibb Co (BMY) is $64.18, with a high forecast of $77.88 and a low forecast of $50.49. This indicates an +8.28% increase from the last price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $54.85 | $53.92 | $57.29 | -7.45% |
| February, 2027 | $55.09 | $53.37 | $57.46 | -7.05% |
| March, 2027 | $58.83 | $50.49 | $59.94 | -0.75% |
| April, 2027 | $62.20 | $58.13 | $63.12 | +4.94% |
| May, 2027 | $62.26 | $58.46 | $62.72 | +5.05% |
| June, 2027 | $66.63 | $62.27 | $66.92 | +12.43% |
| July, 2027 | $70.31 | $64.60 | $71.35 | +18.62% |
| August, 2027 | $73.03 | $70.28 | $75.45 | +23.21% |
| September, 2027 | $73.42 | $70.63 | $75.90 | +23.88% |
| October, 2027 | $71.05 | $68.99 | $74.26 | +19.88% |
| November, 2027 | $72.67 | $71.80 | $77.88 | +22.60% |
| December, 2027 | $72.86 | $69.00 | $73.28 | +22.93% |
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2028
In 2028, Bristol Myers Squibb Co (BMY) is projected to reach an average price of $69.47, with a high projection of $78.74 and a low estimate of $60.20. This indicates an +17.20% rise from the last price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $65.90 | $63.24 | $73.15 | +11.19% |
| February, 2028 | $68.38 | $65.41 | $73.28 | +15.38% |
| March, 2028 | $74.77 | $65.63 | $75.96 | +26.15% |
| April, 2028 | $76.54 | $71.85 | $78.47 | +29.14% |
| May, 2028 | $70.19 | $69.61 | $78.74 | +18.43% |
| June, 2028 | $71.45 | $68.05 | $71.45 | +20.56% |
| July, 2028 | $69.51 | $67.11 | $72.49 | +17.27% |
| August, 2028 | $63.02 | $62.74 | $70.78 | +6.33% |
| September, 2028 | $68.05 | $62.58 | $68.38 | +14.82% |
| October, 2028 | $65.45 | $63.33 | $68.25 | +10.43% |
| November, 2028 | $62.98 | $60.39 | $66.41 | +6.25% |
| December, 2028 | $61.27 | $60.20 | $63.78 | +3.37% |
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2029
The 2029 price forecast for Bristol Myers Squibb Co Stock (BMY) is $51.64 on average, with a high prediction of $62.70 and a low estimate of $40.59. This represents an -12.87% decrease from the previous price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $59.51 | $57.37 | $62.70 | +0.41% |
| February, 2029 | $59.40 | $57.03 | $60.04 | +0.23% |
| March, 2029 | $56.36 | $56.19 | $60.73 | -4.92% |
| April, 2029 | $53.80 | $53.02 | $56.79 | -9.23% |
| May, 2029 | $47.94 | $46.82 | $54.97 | -19.11% |
| June, 2029 | $47.43 | $45.59 | $49.07 | -19.97% |
| July, 2029 | $48.65 | $46.89 | $50.82 | -17.92% |
| August, 2029 | $46.21 | $45.97 | $50.79 | -22.04% |
| September, 2029 | $49.00 | $44.92 | $49.26 | -17.32% |
| October, 2029 | $49.27 | $47.49 | $52.38 | -16.86% |
| November, 2029 | $46.28 | $44.96 | $51.82 | -21.92% |
| December, 2029 | $41.39 | $40.59 | $46.91 | -30.17% |
Bristol Myers Squibb Co Stock (BMY) Price Forecast for 2030
Bristol Myers Squibb Co Stock (BMY) is expected to reach an average price of $49.80 in 2030, with a high forecast of $62.75 and a low forecast of $36.85. This signifies an -15.98% decrease from the last price of $59.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $42.01 | $39.22 | $42.39 | -29.12% |
| February, 2030 | $38.53 | $38.18 | $43.92 | -35.00% |
| March, 2030 | $40.37 | $36.85 | $40.40 | -31.89% |
| April, 2030 | $42.33 | $39.33 | $43.52 | -28.57% |
| May, 2030 | $45.03 | $41.64 | $45.82 | -24.03% |
| June, 2030 | $49.49 | $42.94 | $51.76 | -16.49% |
| July, 2030 | $50.76 | $49.10 | $53.57 | -14.37% |
| August, 2030 | $57.79 | $50.47 | $59.15 | -2.50% |
| September, 2030 | $59.55 | $56.95 | $60.37 | +0.47% |
| October, 2030 | $60.58 | $56.92 | $62.75 | +2.21% |
| November, 2030 | $47.78 | $45.04 | $61.38 | -19.39% |
| December, 2030 | $49.42 | $40.18 | $50.89 | -16.62% |
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):